CRUSADE: A National Quality Improvement Initiative CRUSADE: A National Quality Improvement Initiative Can Rapid Risk Stratification of Unstable Angina.

Slides:



Advertisements
Similar presentations
ACTION Registry (Acute Coronary Treatment and Intervention Outcomes Network) Initial Report 1st Quarter 2007 Results Report prepared by: www. ncdr.com.
Advertisements

What Have We Learned from the CRUSADE Registry
“Adjunctive Therapy” Non ST segment elevation ACS Dr M R Thomas King’s College Hospital. Advanced Angioplasty 2002.
Stanford ACS Guidelines 2003 David P. Lee, M.D. John S. Schroeder, M.D. *Donald Schreiber, M.D. Division of Cardiovascular Medicine and *Department of.
An Immediate Nursing Feedback Program for Primary PCI for ST-segment Elevation Myocardial Infarction Karen Mckenny RN, Theresa Fortner RN, Cheryl McNeil.
Quality Improvement in the Emergency Department Creating the culture so it’s second nature Jonathan A. Edlow, MD Associate Professor of Medicine Harvard.
Healthcare Facilities Accreditation Program (HFAP) Primary Stroke Certification Troy Repuszka, RN, BScN July 16, 2009.
Development of Clinical Pathways to Streamline Care for Patients Presenting with Suspected Cardiac Chest Pain Background The National Heart Foundation.
Very Rapid Treatment of STEMI: Utilizing Pre-Hospital ECGs to Bypass the Emergency Department Kenneth W. Baran, MD Medical Director for United Hospital’s.
Download from Slide 1 AGGRASTAT ® † (tirofiban, MSD) to ZOCOR ™ † (simvastatin, MSD) (A to Z) Trial Results from the AGGRASTAT.
Current State of Use of Evidence- Based Therapies for Acute Coronary Syndromes Strategies to Improve Implementation of Guidelines-Based Care Strategies.
1 What is… ? Disparities Among Women in Acute Cardiac Care Frances Canet, MD Cath Conference Thursday, May 26, 2011.
Safety and Effectiveness of Bivalirudin in NSTE ACS by duration of the upstream infusion in the ACUITY trial: Implications for ED and upstream management.
QI ACTION Registry-Get With The Guidelines The Mission Lifeline Data Solution Kathleen O’Neill, MHA Senior Director, Quality Initiatives IL & SD American.
Slide 1 AGGRASTAT ™ † (tirofiban, MSD) to ZOCOR ™ † (simvastatin, MSD) (A to Z) Trial Results from the AGGRASTAT Phase † Trademarks of Merck & Co., Inc.,
St. Rose Dominican Hospital “Cardiac Care Team” UPDATE September 2003.
STRIVE TM What Is the Evidence That Critical Pathways Work? UCLA Cardiac Hospitalization Atherosclerosis Management Program (CHAMP) ACC Guidelines Applied.
ACUTE MYOCARDIAL INFARCTION Team Membership Clinical Departments: Cardiology, Cardiovascular Surgery, Emergency Medical Services Hospital Departments:
1 EFFECT STUDY 2 EFFECT STUDY  Set national cardiac care benchmarks for hospitals to work towards 
ACS Clinical Pathway. Who? Pts with Acute Ischemic Heart Disease now described as having ACS.
The Center for Health Systems Transformation
Building Clinical Infrastructure and Expert Support Michael Steinberg, MD, FACR ULAAC Disparity Project Centinela/Freeman Health System.
TUESDAY 19TH OCTOBER2010 CATH LAB PRESENTATION. TAO /ACS study STUDY NUMBER: EFC6204 Randomized, double-blind, triple-dummy trial to compare the efficacy.
What are we trying to do?. Acute Phase Driver Diagram.
Impact of Drug-Eluting Stents on Revascularization Choices in Patients with Acute Coronary Syndromes and Multivessel Coronary Disease: Results from the.
National AMI Information Call February 5, 2008 Patient Safety Initiative.
ACTION Registry. Objectives of the NCDR Registries Provide data standardization Provide data that is –Relevant, Credible, Timely, Actionable Present real.
TARGET and TACTICS Clinical Trial Commentary Dr Eric Topol Chairman and Professor, Department of Cardiology Director of the Joseph J Jacobs Center for.
0009COR1 A CRUSADE to Improve Quality of Care for ACS Patients Eric D. Peterson, MD, MPH Associate Professor of Medicine Director of CV Outcomes and Quality.
“Challenging practice in non-ST segment elevation Acute Coronary Syndromes (ACS)” Professor Jennifer Adgey Royal Victoria Hospital, Belfast 26th January.
6/04 CRUSADE: A National Quality Improvement Initiative C an R apid Risk Stratification of U nstable Angina Patients S uppress AD verse Outcomes with E.
The INT egrelin and E noxaparin R andomized assessment of A cute C oronary syndrome Treatment T rial Sponsored by the Canadian Heart Research Centre, Key.
Acute Coronary Syndromes SIGN 93. MINAP Mortality after Acute Coronary Syndromes Cumulative: 13.6% Blue 10.6% Green 11.6% Red.
TCT Presentation October 2006 Outcomes in Elderly Patients Undergoing PCI Treated with Bivalirudin Monotherapy versus Glycoprotein IIb/IIIa Inhibitors.
Acute Coronary Syndromes. Learning outcomes To understand the clinical spectrum of coronary disease To recognise different presentations of the disease.
Clinical Trial Results. org Characteristics, Management, and Outcomes of 5,557 Patients Age ≥90 Years With Acute Coronary Syndromes: Results From the CRUSADE.
Acute Coronary Syndromes in West Hertfordshire Masood Khan.
Cooling Off? Early Intervention? Very Early Intervention? Steve Holmberg Sussex Cardiac Centre.
MICHELANGELO: OASIS 5 Women’s Substudy Dr. Eva Swahn Department of Cardiology, Heart Centre, University Hospital, Linköping Sweden Disclosure Funded by.
The Leeds Teaching Hospitals NHS Trust PHARMACOLOGY IN ACS OVERVIEW OF THE DATA : PRACTICAL ADVICE JIM McLENACHAN, LEEDS. 25 th January, 2007.
GUSTO IV ACS: Trial Design Abciximab versus placebo in very high-risk patients with non-ST elevation acute coronary syndromes: – ST  > 0.5 mm or – elevated.
Acute Myocardial Infarction February 8, 2006.
Annual Patient Admissions for Acute Coronary Syndromes 1.4 MM Non-ST elevation ACS 0.6 MM ST-elevation MI ~ 2.0 MM patients admitted to CCU or telemetry.
Dr.Ali Eshraghi MD Interventional Cardiologist Non STE ACS  Angiographic Findings: 34% 3VD 28%2VD 26%SVD 10%LMCAD Culprit lesion charactristic: eccentric,scalloped,evidence.
NSTEMI Pathway Education for Nurses. Objectives Demonstrate an understanding of the NSTEMI clinical pathway. Understand the importance of early and consistent.
Management of Patients with NSTE ACS Latest Insights from CRUSADE A National Quality Improvement Initiative Eric D. Peterson, MD, MPH Duke Clinical Research.
Duration Safety and Efficacy of Bivalirudin in patients undergoing PCI: The impact of duration of infusion in ACUITY trial Dr. David Cox Lehigh Valley.
Date of download: 6/23/2016 Copyright © The American College of Cardiology. All rights reserved. From: A guide to therapeutic decision-making in patients.
Overview of the Winnipeg CODE STEMI Project Implemented May 2008 Dr.J.Tam MD, FRCP(C), FACC Section Chief Cardiology WRHA and University of Manitoba Lillian.
Bivalirudin Monotherapy Improves 30-day Clinical Outcomes in Diabetics with Acute Coronary Syndrome: Report from the ACUITY Trial Frederick Feit, Steven.
Date of download: 9/17/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2014 AHA/ACC Guideline for the Management of Patients.
Cangrelor Case Presentations
Risk Stratification of Chest Pain: Best Practices
Copyright © 2008 American Medical Association. All rights reserved.
Antiplatelet Therapy For STEMI: The Case for Cangrelor
R. Jay Widmer, MD, PhD, Peter M. Pollak, MD, Malcolm R
Brief History on Mission: Lifeline
Quality Improvement Program: Chest Pain Outpatient Testing
Chapter 28 Management of Patients With Coronary Vascular Disorders
Section A: Introduction
European Heart Association Journal 2007 April
The Time Dependence of Anti-thrombin Initiation in Patients with Non-ST-segment –elevation Acute Coronary Syndrome: Subgroup Analysis form the ACUITY.
The following slides are based on a presentation at a Satellite Symposium in association with the Annual Cardiovascular Conference at Lake Louise, Alberta,
Section F: Clinical guidelines
2006 CRUSADE 2nd Quarter Results
TIMI IIIA Protocol Design 391 Patients with Unstable Angina / NQWMI
Quality Improvement Programs and Critical Pathways
OASIS-5: Study Design Randomize N=20,078 Enoxaparin (N=10,021)
R. Jay Widmer, MD, PhD, Peter M. Pollak, MD, Malcolm R
Many post-MI patients are not receiving optimal therapy
Presentation transcript:

CRUSADE: A National Quality Improvement Initiative CRUSADE: A National Quality Improvement Initiative Can Rapid Risk Stratification of Unstable Angina Patients Suppress ADverse Outcomes with Early Implementation of the ACC/AHA Guidelines Can Rapid Risk Stratification of Unstable Angina Patients Suppress ADverse Outcomes with Early Implementation of the ACC/AHA Guidelines

AHA/ACC Treatment Recommendations n Aspirin n Aspirin + Clopidogrel n Beta-Blockers n Heparin (UFH or LMWH) n GP IIb/IIIa Inhibitors l For high-risk patients l For early cath/PCI n Aspirin n Aspirin + Clopidogrel n Beta-Blockers n Heparin (UFH or LMWH) n GP IIb/IIIa Inhibitors l For high-risk patients l For early cath/PCI n Aspirin n Aspirin + Clopidogrel n Beta-Blockers n Statins n ACE-Inhibitors n Cardiac Rehab n Smoking Cessation Acute Therapies Discharge Therapies

CRUSADE Objectives n Determine current state of awareness of and adherence to the ACC/AHA Non-ST-Elevation (NSTE) ACS Guidelines n Implement quality improvement initiatives to promote ACC/AHA NSTE ACS recommendations n Improve clinical outcomes for NSTE ACS patients via early risk stratification and implementation of evidence-based care n Determine current state of awareness of and adherence to the ACC/AHA Non-ST-Elevation (NSTE) ACS Guidelines n Implement quality improvement initiatives to promote ACC/AHA NSTE ACS recommendations n Improve clinical outcomes for NSTE ACS patients via early risk stratification and implementation of evidence-based care

Inclusion Criteria: High-Risk NSTE ACS n Ischemic symptoms lasting  10 minutes < 24 hours and at least one of the following: n Positive cardiac markers l CK-MB or TnI / TnT above ULN l Positive bedside troponin assay n Dynamic ST-segment ECG changes: l ST-segment depression  0.5 mm l Transient ST-segment elevation of mm (lasting < 10 mins) n Transfer patients - must arrive at CRUSADE hospital within 24 hrs of symptoms n Ischemic symptoms lasting  10 minutes < 24 hours and at least one of the following: n Positive cardiac markers l CK-MB or TnI / TnT above ULN l Positive bedside troponin assay n Dynamic ST-segment ECG changes: l ST-segment depression  0.5 mm l Transient ST-segment elevation of mm (lasting < 10 mins) n Transfer patients - must arrive at CRUSADE hospital within 24 hrs of symptoms

Study Design n Nationwide quality improvement initiative l 400+ participating hospitals n Collaborative effort between Emergency Medicine, Cardiology, Hospital QI, Academia, and Industry l Optimize risk stratification for NSTE ACS patients l Promote adherence to ACC/AHA treatment guidelines for NSTE ACS l Implement quality improvement interventions n Nationwide quality improvement initiative l 400+ participating hospitals n Collaborative effort between Emergency Medicine, Cardiology, Hospital QI, Academia, and Industry l Optimize risk stratification for NSTE ACS patients l Promote adherence to ACC/AHA treatment guidelines for NSTE ACS l Implement quality improvement interventions

Data Collection n Concise, 3-page data collection form l Retrospective data collection l Payment of $20 per DCF returned n Data collected includes: l Pt risk factors/presenting symptoms l Use of medications/ Use of invasive procedures/In-hospital clinical outcomes n Institutional Review Boards: l Should not require informed consent l Should be viewed by local IRB as QI n Concise, 3-page data collection form l Retrospective data collection l Payment of $20 per DCF returned n Data collected includes: l Pt risk factors/presenting symptoms l Use of medications/ Use of invasive procedures/In-hospital clinical outcomes n Institutional Review Boards: l Should not require informed consent l Should be viewed by local IRB as QI

Quality Improvement Initiative: Primary Endpoints n Effectiveness of QI initiatives measured by changes in adherence to AHA/ACC treatment guidelines l Early / Discharge aspirin and clopidogrel use l Early / Discharge beta-blocker use l Discharge ACE-Inhibitor and statin use l GP IIb/IIIa Inhibitors: Early use and during PCI l Early invasive management - use of cath/PCI/CABG l Appropriate secondary prevention measures Smoking cessation Smoking cessation Cardiac rehabilitation Cardiac rehabilitation n Effectiveness of QI initiatives measured by changes in adherence to AHA/ACC treatment guidelines l Early / Discharge aspirin and clopidogrel use l Early / Discharge beta-blocker use l Discharge ACE-Inhibitor and statin use l GP IIb/IIIa Inhibitors: Early use and during PCI l Early invasive management - use of cath/PCI/CABG l Appropriate secondary prevention measures Smoking cessation Smoking cessation Cardiac rehabilitation Cardiac rehabilitation

Patient Identification Strategies Screening in the Emergency Department n Prospectively identify patients in the ED l Elevated cardiac markers, dynamic ECG changes l Rapid, bedside Troponin I assays in the ED n Review daily ED admission logs l Unstable angina, chest pain, R/O MI, or acute MI n Review admissions to chest pain units n Develop triggers for ED nursing staff to identify patients for CRUSADE n Work with research coordinators who are screening patients for ACS clinical trials n Prospectively identify patients in the ED l Elevated cardiac markers, dynamic ECG changes l Rapid, bedside Troponin I assays in the ED n Review daily ED admission logs l Unstable angina, chest pain, R/O MI, or acute MI n Review admissions to chest pain units n Develop triggers for ED nursing staff to identify patients for CRUSADE n Work with research coordinators who are screening patients for ACS clinical trials

Patient Identification Strategies Screening After Admission n Review daily CCU or telemetry floor admission logs l Unstable angina, chest pain, R/O MI, or acute MI n Review daily cath lab schedule l Unstable angina, acute MI n Develop triggers for CCU / telemetry floor nurses to identify patients for CRUSADE n Screen all patients with elevated cardiac marker levels from local laboratory records n Review daily CCU or telemetry floor admission logs l Unstable angina, chest pain, R/O MI, or acute MI n Review daily cath lab schedule l Unstable angina, acute MI n Develop triggers for CCU / telemetry floor nurses to identify patients for CRUSADE n Screen all patients with elevated cardiac marker levels from local laboratory records

Patient Identification Strategies Screening After Discharge n Review discharge diagnoses for chest pain l Unstable angina, chest pain, R/O MI, or acute MI l New ICD-9 codes for acute MI: + TnT/TnI n Review all patients with elevated cardiac marker levels from local laboratory records n Pull charts after identification of patients to fill out items on the data collection form n Review discharge diagnoses for chest pain l Unstable angina, chest pain, R/O MI, or acute MI l New ICD-9 codes for acute MI: + TnT/TnI n Review all patients with elevated cardiac marker levels from local laboratory records n Pull charts after identification of patients to fill out items on the data collection form

Quality Improvement Initiatives: n Regional educational meetings l ACC/AHA Guidelines recommendations l Review CRUSADE and QI Initiatives n Site Survey l Understand site beliefs and practice environment n Educational / QI materials l ED Risk Stratification Algorithm/ Sample orders l Guidelines Posters/pocket cards l Discharge MD and patient check lists n Quarterly Feedback Reports n Regional educational meetings l ACC/AHA Guidelines recommendations l Review CRUSADE and QI Initiatives n Site Survey l Understand site beliefs and practice environment n Educational / QI materials l ED Risk Stratification Algorithm/ Sample orders l Guidelines Posters/pocket cards l Discharge MD and patient check lists n Quarterly Feedback Reports

Quality Improvement Initiatives: Hospital Survey Component n Baseline understanding of and concurrence with AHA/ACC NSTE ACS treatment guidelines l Is it an education versus adherence issue? n Identify local features which may serve to promote quality improvement initiatives l Survey “structure and culture” of institution l Do institutional characteristics predict improved adherence to guidelines-based care? n Baseline understanding of and concurrence with AHA/ACC NSTE ACS treatment guidelines l Is it an education versus adherence issue? n Identify local features which may serve to promote quality improvement initiatives l Survey “structure and culture” of institution l Do institutional characteristics predict improved adherence to guidelines-based care?

Quality Improvement Initiatives: Data Reporting to Sites n Quarterly feedback reports to sites regarding their adherence to ACC/AHA treatment guidelines l Focused on AHA/ACC Guidelines treatments l Site confidentiality maintained - data supplied back to sites in a secure fashion l Provides sites with benchmark performance data n Quarterly feedback reports to sites regarding their adherence to ACC/AHA treatment guidelines l Focused on AHA/ACC Guidelines treatments l Site confidentiality maintained - data supplied back to sites in a secure fashion l Provides sites with benchmark performance data

Sample Quarterly Report: GP IIb/IIa Inhibitor Use in First 24 Hours

Site Participants and Responsibilities n Emergency Medicine and Cardiology Co-Advocates l Develop strategies to identify high-risk NSTE ACS patients early during hospitalization l Implement QI tools to promote ACC/AHA Guidelines n QI nurse or research coordinator l Completion of case report forms l Assist in local educational/QI efforts to increase adherence to ACC/AHA Guidelines n Emergency Medicine and Cardiology Co-Advocates l Develop strategies to identify high-risk NSTE ACS patients early during hospitalization l Implement QI tools to promote ACC/AHA Guidelines n QI nurse or research coordinator l Completion of case report forms l Assist in local educational/QI efforts to increase adherence to ACC/AHA Guidelines

Promoting a New Paradigm of Evidence-Based Cardiovascular Care n The CRUSADE national quality improvement initiative will teach us much about: l Why current ACC/AHA treatment guidelines for ACS are not followed l What initiatives can improve adherence l How to promote EM-Cardiology collaboration l Will improved early adherence to treatment guidelines lead to better acute outcomes? n The CRUSADE national quality improvement initiative will teach us much about: l Why current ACC/AHA treatment guidelines for ACS are not followed l What initiatives can improve adherence l How to promote EM-Cardiology collaboration l Will improved early adherence to treatment guidelines lead to better acute outcomes?